KIDS - NASDAQ
OrthoPediatrics Corp.
$16.92
+0.65%OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
At a Glance
Live SnapshotOrthoPediatrics Corp. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
OrthoPediatrics Corp. Cash Flow Statement
KIDS • NASDAQ
| OrthoPediatrics Corp. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||
-39.6M | -37.8M | -21M | 1.3M | -16.3M | -32.9M | -13.7M | -12M | -8.9M | -6.6M | -7.9M | -9.5M | |
21.1M | 19.1M | 17.4M | 13.1M | 10.7M | 8M | 4.7M | 2.9M | 2.4M | 1.9M | 1.9M | 1.6M | |
-153K | -4.7M | -1.2M | -5M | -1.1M | -723K | -144K | 0.0 | 0.0 | 0.0 | -1.2M | -706K | |
17.8M | 13.5M | 10.5M | 6.7M | 5.8M | 6.2M | 2.6M | 3.2M | 3.5M | 1.3M | 1.2M | 706K | |
6.8M | 5.8M | -623K | -20M | 354K | 5.9M | 210K | 19.1M | 12.3M | -889K | 1.2M | 706K | |
-10.8M | -22.9M | -32.2M | -17.8M | -12.6M | -5M | -11.4M | -9.6M | -4.2M | 3.2M | 3.9M | -2.7M | |
-4.9M | -27M | -27M | -21.8M | -13.1M | -18.5M | -17.8M | -15.6M | -7.2M | -1.1M | -892K | -9.9M | |
INVESTING ACTIVITIES | ||||||||||||
-11.1M | -14.3M | -16.9M | -10M | -16M | -11.3M | -12.1M | -5.5M | -6.5M | -4.8M | -2.3M | -3.3M | |
-15.5M | -20.2M | -3.6M | -40.1M | (0.0) | -3.4M | -49.8M | (0.0) | (0.0) | (0.0) | (539K) | (0.0) | |
-17M | -25.6M | -48.6M | -110.1M | (0.0) | -55M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 49.9M | 112.9M | 46.9M | 9.3M | 796K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | -2.9M | -2.1M | 0.0 | -650K | -796K | 0.0 | -502K | -1.3M | -406K | 539K | 42K | |
-43.6M | -13.2M | (41.7M) | -113.4M | -7.4M | -69.7M | -61.9M | -6M | -6.5M | -4.8M | -1.7M | -3.3M | |
FINANCING ACTIVITIES | ||||||||||||
0.0 | 0.0 | 21K | 139.3M | 137K | 70.2M | 60M | 43.4M | 52.8M | 0.0 | 0.0 | 0.0 | |
24M | 56.5M | 9.3M | -137K | -131K | -25.1M | 29.9M | -4.2M | 7.9M | 4.4M | -98K | 2.9M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -6M | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -990K | (0.0) | (0.0) | (0.0) | |
0.0 | -3.4M | -2M | -3.2M | 0.0 | 1.7M | 1.1M | 410K | 0.0 | -794K | 0.0 | 0.0 | |
24M | 53.1M | 7.3M | 136M | 6K | 46.7M | 91M | 39.7M | 54.7M | 3.6M | -98K | 19.7M | |
CASH FLOW SUMMARY | ||||||||||||
348K | -175K | 633K | 619K | -658K | -404K | 8K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
-24.2M | 12.8M | 22.6M | 1.5M | -21.1M | -41.9M | 11.3M | 18.1M | 41M | -2.3M | -2.7M | 6.5M | |
45.8M | 33M | 10.5M | 9M | 30.1M | 72M | 60.7M | 42.6M | 1.6M | 3.9M | 6.6M | 58K | |
21.6M | 45.8M | 33M | 10.5M | 9M | 30.1M | 72M | 60.7M | 42.6M | 1.6M | 3.9M | 6.6M | |
-16M | -41.3M | -46M | -31.8M | -29.1M | -29.8M | -29.9M | -21M | -13.8M | -5.9M | -3.1M | -13.2M |
SEC Filings
KIDS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 01, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 20, 2026 | April 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 31, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 04, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 |
Related Guides
Continue your KIDS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.